The private equity–owned ER doctor practice, now headed to bankruptcy, was one of the defining companies of 21st-century American medicine.
Medicare
Posted inHealth and Social Policy
Regulators on the Verge of Bungling Drug Price Reform, Advocates Say
The starting point for negotiations with drug companies on prescription prices could end up being the too-high prices patients already live with.
Posted inHealth and Social Policy
Born to Die
Medicare spends tens of billions of dollars on hospice care each year. A new report ponders why regulators insist on going easy on literal death merchants.
Posted inHealth and Social Policy
Insurance Lobbyists Force Government to Heel on Medicare Advantage
But advocates see an opening for reining in the worst abuses of the program.
Posted inHealth and Social Policy
California Goes In for Drugmaking
The state will make and distribute insulin at cost. That should be a model for every other state.
Posted inHealth and Social Policy
The Fight for Mental Health Parity
The expiration of the COVID public-health emergency will make it harder to obtain treatment. But hurdles already existed in the law.
Posted inTAP
A Small Victory Over Big Pharma
Today on TAP: Eli Lilly announces insulin price caps, but keep an eye on the footnotes.
Posted inHealth and Social Policy
Private Health Care Companies Are Eating the American Economy
A new report from Wendell Potter at the Center for Health and Democracy examines just how the private insurance market makes its money—and how American health care is worse off for it.
Posted inMoney, Politics, and Power
Critical Tests for the Biden Administration’s New Team
If the new chief of staff and National Economic Council Director want to prove that they aren’t diverting the administration back to a neoliberal footing, here are a few options.
